MetLife, Inc.
MET · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $69,939 | $67,709 | $67,965 | $63,366 |
| % Growth | 3.3% | -0.4% | 7.3% | – |
| Cost of Goods Sold | $50,940 | $50,420 | $49,029 | $46,531 |
| Gross Profit | $18,999 | $17,289 | $18,936 | $16,835 |
| % Margin | 27.2% | 25.5% | 27.9% | 26.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5,991 | $6,177 | $5,860 | $5,755 |
| SG&A Expenses | $5,991 | $6,177 | $5,860 | $5,755 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7,386 | $8,950 | $6,712 | $2,562 |
| Operating Expenses | $13,377 | $15,127 | $12,572 | $8,317 |
| Operating Income | $5,622 | $2,162 | $6,364 | $8,518 |
| % Margin | 8% | 3.2% | 9.4% | 13.4% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $5,622 | $2,162 | $6,364 | $8,518 |
| Tax Expense | $1,178 | $560 | $1,062 | $1,642 |
| Net Income | $4,426 | $1,578 | $5,284 | $6,855 |
| % Margin | 6.3% | 2.3% | 7.8% | 10.8% |
| EPS | 5.98 | 1.82 | 6.35 | 7.7 |
| % Growth | 228.6% | -71.3% | -17.5% | – |
| EPS Diluted | 5.94 | 1.81 | 6.3 | 7.65 |
| Weighted Avg Shares Out | 689 | 762 | 779 | 826 |
| Weighted Avg Shares Out Dil | 711 | 762 | 809 | 869 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,037 | $1,045 | $938 | $920 |
| Depreciation & Amortization | $714 | $718 | $673 | $694 |
| EBITDA | $7,373 | $3,925 | $7,975 | $10,132 |
| % Margin | 10.5% | 5.8% | 11.7% | 16% |